Research programme: metabolic disorders therapeutics - LG Life SciencesAlternative Names: Cell protectant; GK Activator
Latest Information Update: 22 Oct 2014
At a glance
- Originator LG Life Sciences
- Mechanism of Action Cell modulators; Glucokinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic disorders; Type 2 diabetes mellitus
Most Recent Events
- 22 Oct 2014 Early research is ongoing in South Korea
- 20 Jul 2012 Early research in Metabolic disorders in South Korea (unspecified route)
- 20 Jul 2012 Early research in Type-2 diabetes mellitus in South Korea (unspecified route)